Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Radford

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Immunology|July 1, 1996
Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acidD Chen, G Radford-Smith, M C Dipaolo, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2013
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximabA Croft, A Walsh, J Doecke, et al.
Mayo Clinic Proceedings|October 1, 1994
Renal biopsy in clinical practiceM G Radford, J V Donadio, K E Holley, et al.
Journal of Clinical Pathology|July 9, 2002
A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kitsR C W Wong, R J Wilson, R H Steele, et al.
Journal of Environmental Management|October 31, 2024
Predicting burn probability: Dimensionality reduction strategies enable accurate and computationally efficient metamodelingDouglas A G Radford, Holger R Maier, Hedwig van Delden, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trialB G Feagan, W J Sandborn, G Lichtenstein, et al.
Anaesthesia|January 1, 1982
The fibrinolytic effects of anaesthesiaP J Simpson, S G Radford, S J Forster, et al.
Gut|September 14, 2004
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trialW J Sandborn, B G Feagan, G Radford-Smith, et al.
JAMA|August 14, 1996
Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugsM G Radford, K E Holley, J P Grande, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitisP R Gibson, B Fixa, B Pekárková, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Immunology|July 1, 1996
Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acidD Chen, G Radford-Smith, M C Dipaolo, et al.
Alimentary Pharmacology & Therapeutics|June 22, 2013
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximabA Croft, A Walsh, J Doecke, et al.
Mayo Clinic Proceedings|October 1, 1994
Renal biopsy in clinical practiceM G Radford, J V Donadio, K E Holley, et al.
Journal of Clinical Pathology|July 9, 2002
A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kitsR C W Wong, R J Wilson, R H Steele, et al.
Journal of Environmental Management|October 31, 2024
Predicting burn probability: Dimensionality reduction strategies enable accurate and computationally efficient metamodelingDouglas A G Radford, Holger R Maier, Hedwig van Delden, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trialB G Feagan, W J Sandborn, G Lichtenstein, et al.
Anaesthesia|January 1, 1982
The fibrinolytic effects of anaesthesiaP J Simpson, S G Radford, S J Forster, et al.
Gut|September 14, 2004
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trialW J Sandborn, B G Feagan, G Radford-Smith, et al.
JAMA|August 14, 1996
Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugsM G Radford, K E Holley, J P Grande, et al.
Alimentary Pharmacology & Therapeutics|April 1, 2006
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitisP R Gibson, B Fixa, B Pekárková, et al.
Pageof 6